These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
These kits are intended for in vitro diagnostic use.
These kits are for research use only and are not intended to be used for diagnostic procedures.
Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
Biological risk products.
Storage between 2 and 8 ° C.
Reactive in liquid form.
Reactive in lyophilized form.
Reactive in frozen form.
Stability after opening at 2-8 ° C.
Products that can be refrozen.
Stability 12 months after refreezing at -20 ° C.
Sodium acetate, 0.15 M sodium chloride, pH 5.3.
MW(Da) : 86 000
Extinction coef. : 11.7
The Safety Data Sheets and Notices are accessible to our registered customers.
Prekallikrein is a glycoprotein, a serine protease zymogen.
Non-covalently complexed with high molecular weight kininogen.
Prekallikrein participates in the activation of coagulation, fibrinolysis, kinin generation and inflammatory phenomena. It is activated to kallikrein by FXIIa.
The protein is > 95% pure according to SDS-PAGE gels and shows no reduction when incubated with 2-mercaptoethanol.
We recommend that you reconstitute the vial in the original volume with filtered deionized water.
All proteins are accompanied by certificates of analysis which describe the appropriate storage conditions.
In order for us to guarantee the stability of the product, it is imperative that the storage conditions are observed.
Avoid freezing and thawing cycles.
1 vial containing 1.0 mg of lyophilized 4 mM protein